Names and pronunciation
(oh-bet-i-koe′lik as′id) Ocaliva
PDF page 968
Drug reference
(oh-bet-i-koe′lik as′id) Ocaliva
PDF page 968
Func. class.: Farnesoid X receptor agonist
PDF page 968
USES: Treatment of primary biliary cholangitis (PBC) in combination with ursodiol (ursodeoxycholic acid) with an inadequate response to ursodiol, or in those unable to tolerate ursodiol
PDF page 968
DOSAGE AND ROUTES Adult: PO Noncirrhotic or compen- sated Child-Pugh class A: Initial: 5 mg daily; if an adequate reduction in alkaline phosphatase and/or total bilirubin has not been achieved after 3 mo, increase to 10 mg daily, max 10 mg/day Hepatic dose • Adult: PO Child-Pugh B-C 5 mg weekly ×3 mo then increase as needed
PDF page 968
Available forms: Tabs 5, 10 mg HIGH ALERT
PDF page 968
• Adult: PO Child-Pugh B-C 5 mg weekly ×3 mo then increase as needed
PDF page 968